Log in
Enquire now
‌

US Patent 7041298 Proteolysis targeting chimeric pharmaceutical

Patent 7041298 was granted and assigned to California Institute of Technology on May, 2006 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
California Institute of Technology
California Institute of Technology
0
Date Filed
September 10, 2001
0
Date of Patent
May 9, 2006
0
Patent Application Number
09953473
0
Patent Citations Received
‌
US Patent 12091411 IRAK degraders and uses thereof
0
‌
US Patent 12076405 Heterocyclic degronimers for target protein degradation
0
‌
US Patent 12077509 Compounds and methods for the targeted degradation of androgen receptor
0
‌
US Patent 12077555 STAT degraders and uses thereof
0
‌
US Patent 12091397 Dihydroquinolinones for medical treatment
0
‌
US Patent 11834460 Imide-based modulators of proteolysis and associated methods of use
0
‌
US Patent 11857519 Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
0
‌
US Patent 11883393 Compounds and methods for the targeted degradation of androgen receptor
0
‌
US Patent 11912699 Tau-protein targeting compounds and associated
0
‌
US Patent 11932635 CRBN ligands and uses thereof
0
•••
Patent Inventor Names
Craig Crews
0
Kathleen M. Sakamoto
0
Raymond J. Deshaies
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7041298
0
Patent Primary Examiner
‌
Ulrike Winkler
0

Find more entities like US Patent 7041298 Proteolysis targeting chimeric pharmaceutical

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.